Previous Article | Next Article 
Journal of Virology, February 2002, p. 1626-1631, Vol. 76, No. 4
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.76.4.1626-1631.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Nef-Mediated Resistance of Human Immunodeficiency Virus Type 1 to Antiviral Cytotoxic T Lymphocytes
Otto O. Yang,1,2* Phuong Thi Nguyen,3 Spyros A. Kalams,3 Tanya Dorfman,4 Heinrich G. Göttlinger,4 Sheila Stewart,2 Irvin S. Y. Chen,2 Steven Threlkeld,3 and Bruce D. Walker3
Division of Infectious Diseases,1
AIDS Institute, UCLA Medical Center, Los Angeles, California 90095,2
Partners AIDS Research Center and Infectious Disease Unit, Massachusetts General Hospital-East, Charlestown, Massachusetts 02129,3
Dana Farber Cancer Institute, Boston, Massachusetts 021154
Received 30 August 2001/
Accepted 13 November 2001
Although Nef has been proposed to effect the escape of human immunodeficiency virus type 1 (HIV-1) from cytotoxic T lymphocytes (CTL) through downmodulation of major histocompatibility complex class I molecules, little direct data have been presented previously to support this hypothesis. By comparing nef-competent and nef-deleted HIV-1 strains in an in vitro coculture system, we demonstrate that the presence of this viral accessory gene leads to impairment of the ability of HIV-1-specific CTL clones to suppress viral replication. Furthermore, inhibition by genetically modified CTL that do not require major histocompatibility complex class I-presented antigen (expressing the CD4 T-cell receptor [TCR]
-chain hybrid receptor) is similar for both nef-competent and -deleted strains, indicating that Nef does not impair the effector functions of CTL but acts at the level of TCR triggering. In contrast, we note that another accessory gene, vpr, does not induce resistance of HIV-1 to suppression by CTL clones. We conclude that Nef (and not Vpr) contributes to functional HIV-1 immune evasion and that this effect is mediated by diminished antigen presentation to CTL.
* Corresponding author. Mailing address: Division of Infectious Diseases, 37-121 CHS, UCLA Medical Center, 10833 LeConte Ave., Los Angeles, CA 90095. Phone: (310) 794-9491. Fax: (310) 825-3632. E-mail:
oyang{at}mednet.ucla.edu.
Journal of Virology, February 2002, p. 1626-1631, Vol. 76, No. 4
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.76.4.1626-1631.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Nou, E., Zhou, Y., Nou, D. D., Blankson, J. N.
(2009). Effective Downregulation of HLA-A*2 and HLA-B*57 by Primary Human Immunodeficiency Virus Type 1 Isolates Cultured from Elite Suppressors. J. Virol.
83: 6941-6946
[Abstract]
[Full Text]
-
Wick, W. D., Gilbert, P. B., Yang, O. O.
(2009). Predicting the Impact of Blocking Human Immunodeficiency Virus Type 1 Nef In Vivo. J. Virol.
83: 2349-2356
[Abstract]
[Full Text]
-
Walker, B. D., Burton, D. R.
(2008). Toward an AIDS Vaccine. Science
320: 760-764
[Abstract]
[Full Text]
-
DeGottardi, M. Q., Specht, A., Metcalf, B., Kaur, A., Kirchhoff, F., Evans, D. T.
(2008). Selective Downregulation of Rhesus Macaque and Sooty Mangabey Major Histocompatibility Complex Class I Molecules by Nef Alleles of Simian Immunodeficiency Virus and Human Immunodeficiency Virus Type 2. J. Virol.
82: 3139-3146
[Abstract]
[Full Text]
-
Lewis, M. J., Balamurugan, A., Ohno, A., Kilpatrick, S., Ng, H. L., Yang, O. O.
(2008). Functional Adaptation of Nef to the Immune Milieu of HIV-1 Infection In Vivo. J. Immunol.
180: 4075-4081
[Abstract]
[Full Text]
-
Noviello, C. M., Benichou, S., Guatelli, J. C.
(2008). Cooperative Binding of the Class I Major Histocompatibility Complex Cytoplasmic Domain and Human Immunodeficiency Virus Type 1 Nef to the Endosomal AP-1 Complex via Its {micro} Subunit. J. Virol.
82: 1249-1258
[Abstract]
[Full Text]
-
Sacha, J. B., Chung, C., Reed, J., Jonas, A. K., Bean, A. T., Spencer, S. P., Lee, W., Vojnov, L., Rudersdorf, R., Friedrich, T. C., Wilson, N. A., Lifson, J. D., Watkins, D. I.
(2007). Pol-Specific CD8+ T Cells Recognize Simian Immunodeficiency Virus-Infected Cells Prior to Nef-Mediated Major Histocompatibility Complex Class I Downregulation. J. Virol.
81: 11703-11712
[Abstract]
[Full Text]
-
Adnan, S., Balamurugan, A., Trocha, A., Bennett, M. S., Ng, H. L., Ali, A., Brander, C., Yang, O. O.
(2006). Nef interference with HIV-1-specific CTL antiviral activity is epitope specific. Blood
108: 3414-3419
[Abstract]
[Full Text]
-
Kasper, M. R., Roeth, J. F., Williams, M., Filzen, T. M., Fleis, R. I., Collins, K. L.
(2005). HIV-1 Nef Disrupts Antigen Presentation Early in the Secretory Pathway. J. Biol. Chem.
280: 12840-12848
[Abstract]
[Full Text]
-
Tomiyama, H., Fujiwara, M., Oka, S., Takiguchi, M.
(2005). Cutting Edge: Epitope-Dependent Effect of Nef-Mediated HLA Class I Down-Regulation on Ability of HIV-1-Specific CTLs to Suppress HIV-1 Replication. J. Immunol.
174: 36-40
[Abstract]
[Full Text]
-
Swigut, T., Alexander, L., Morgan, J., Lifson, J., Mansfield, K. G., Lang, S., Johnson, R. P., Skowronski, J., Desrosiers, R.
(2004). Impact of Nef-Mediated Downregulation of Major Histocompatibility Complex Class I on Immune Response to Simian Immunodeficiency Virus. J. Virol.
78: 13335-13344
[Abstract]
[Full Text]
-
Allen, T. M., Altfeld, M., Yu, X. G., O'Sullivan, K. M., Lichterfeld, M., Le Gall, S., John, M., Mothe, B. R., Lee, P. K., Kalife, E. T., Cohen, D. E., Freedberg, K. A., Strick, D. A., Johnston, M. N., Sette, A., Rosenberg, E. S., Mallal, S. A., Goulder, P. J. R., Brander, C., Walker, B. D.
(2004). Selection, Transmission, and Reversion of an Antigen-Processing Cytotoxic T-Lymphocyte Escape Mutation in Human Immunodeficiency Virus Type 1 Infection. J. Virol.
78: 7069-7078
[Abstract]
[Full Text]
-
Yamada, T., Watanabe, N., Nakamura, T., Iwamoto, A.
(2004). Antibody-Dependent Cellular Cytotoxicity via Humoral Immune Epitope of Nef Protein Expressed on Cell Surface. J. Immunol.
172: 2401-2406
[Abstract]
[Full Text]
-
Ali, A., Lubong, R., Ng, H., Brooks, D. G., Zack, J. A., Yang, O. O.
(2004). Impacts of Epitope Expression Kinetics and Class I Downregulation on the Antiviral Activity of Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocytes. J. Virol.
78: 561-567
[Abstract]
[Full Text]
-
Ali, A., Pillai, S., Ng, H., Lubong, R., Richman, D. D., Jamieson, B. D., Ding, Y., McElrath, M. J., Guatelli, J. C., Yang, O. O.
(2003). Broadly Increased Sensitivity to Cytotoxic T Lymphocytes Resulting from Nef Epitope Escape Mutations. J. Immunol.
171: 3999-4005
[Abstract]
[Full Text]
-
Yang, O. O., Sarkis, P. T. N., Ali, A., Harlow, J. D., Brander, C., Kalams, S. A., Walker, B. D.
(2003). Determinants of HIV-1 Mutational Escape From Cytotoxic T Lymphocytes. JEM
197: 1365-1375
[Abstract]
[Full Text]
-
Kasper, M. R., Collins, K. L.
(2003). Nef-Mediated Disruption of HLA-A2 Transport to the Cell Surface in T Cells. J. Virol.
77: 3041-3049
[Abstract]
[Full Text]
-
Kawana-Tachikawa, A., Tomizawa, M., Nunoya, J.-i., Shioda, T., Kato, A., Nakayama, E. E., Nakamura, T., Nagai, Y., Iwamoto, A.
(2002). An Efficient and Versatile Mammalian Viral Vector System for Major Histocompatibility Complex Class I/Peptide Complexes. J. Virol.
76: 11982-11988
[Abstract]
[Full Text]